US2001049374A1PendingUtilityA1
Urokinase inhibitors
Priority: Aug 6, 1997Filed: May 8, 2001Published: Dec 6, 2001
Est. expiryAug 6, 2017(expired)· nominal 20-yr term from priority
Inventors:Andrew SteeleWilliam J. McclellanTodd W. RockwayKent D. StewartMoshe WeitzbergMichael D. WendtVicki Nienaber
C07C 2601/02C07C 275/42C07C 311/16C07D 307/18C07D 213/74C07C 323/60C07C 311/13C07C 271/22C07C 257/18C07C 2601/14C07C 2601/08C07C 2601/04C07B 2200/09C07D 307/79C07D 333/24C07D 231/12C07B 2200/07C07C 323/62C07D 295/088C07C 271/30C07C 271/64C07D 217/02C07D 239/42C07C 275/64C07D 295/155C07C 2601/10C07C 271/28C07D 241/18C07C 2602/08C07D 307/54C07D 277/30C07C 259/18C07C 275/40C07D 307/64
41
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compounds having the formula are inhibitors of urokinase and are useful in the treatment of diseases in which urokinase plays a role. Also disclosed are urokinase-inhibiting compositions and a method of inhibiting urokinase in a mammal.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A compound having the formula
Z is selected from the group consisting of
(1) nitrogen;
(2) methine; and
(3) methine substituted with —NR 1 R 2 ;
A is selected from the group consisting of
(1) hydrogen and
(2) —L A R A ;
B is selected from the group consisting of
(1) hydrogen and
(2) —L B R B and
C is selected from the group consisting of
(1) hydrogen and
(2) —L C R C ,
with the proviso that at least one of A, B or C is other than hydrogen; and with the proviso that when A is other than hydrogen, at least one of B or C is other than hydrogen,
wherein for A, B, and C, L A , L B and L C are independently selected from the group consisting of
(1) a covalent bond,
(2) —(CH 2 ) m —,
(3) —NR 1 —,
(4) —NR 2 C(X)NR 3 —,
(5) —C(X)—,
(6) —NR 1 C(X)—
(7) —C(X)NR 2 —,
(8) —CH═CH—,
(9) —C≡C—,
(10) —O—
(11) —S(O) t —,
(12) —C≡C(CH 2 ) n NR 2 C(X)—,
(13) —C(X)NR 2 (CH 2 ) n C≡C—,
(14) —(CH 2 ) n NSO 2 —,
(15) —NR 2 SO 2 (CH 2 ) n C≡C—,
(16) —C≡C(CH 2 ) n NR 2 SO 2 NR 3 —,
(17) —NR 2 SO 2 NR 3 (CH 2 ) n C≡C—,
(18) —SO 2 NR 2 —,
(19) —NR 2 SO 2 —,
(20) —NR 2 SO 2 NR 3 —,
(21) —N═N—,
(22) —C(X)N(OR 2 )—,
(23) —N(OR 2 )C(X)—,
(24) —HC═CH(CH 2 ) n NR 2 C(X)—,
(25) —(CH 2 ) n NR 2 C(X)CH═CH—,
(26) —CH═CH(CH 2 ) n NSO 2 —,
(27) —NR 2 SO 2 (CH 2 ) n CH═CH—,
(28) —(CH 2 ) n NR 2 SO 2 NR 3 —,
(29) —NR 2 SO 2 NR 3 (CH 2 ) n CH═CH—,
(30) —NR 2 C(O)O—,
(31) —OC(O)NR 2 —,
(32) —CH═NO—,
(33) —ON═CH— and
(34)
wherein W is selected from the group consisting of
(a) —O—,
(b) —S—,
(c) —NR 1 — and
(d) —(CH 2 ) m —,
wherein each functional group is depicted with its right-hand end being the end which is attached to the naphthyl or quinolyl ring and its left-hand end being the end which is attached to R A , R B or R C ;
R A , R B and R C are independently selected from the group consisting of
(1) aryl;
(2) arylalkoxy, wherein the alkylene group is of one to six carbon atoms;
(3) alkyl of one to ten carbon atoms;
(4) alkenyl of two to ten carbon atoms;
(5) alkoxycarbonyl of one to six carbon atoms;
(6) alkynyl of two to ten carbon atoms;
(7) halogen;
(8) —NR 1 R 2 ;
(9) heterocycle;
(10) cycloalkenyl of four to twelve carbon atoms;
(11) cycloalkyl of three to twelve carbon atoms;
(12) —NR 1 C(O)NR 2 R 3 ; and
(13) —NR 1 C(O)R 50 , wherein R 50 is alkyl of one to six carbon atoms; wherein, at each occurence, R 1 is selected from the group consisting of
(1) hydrogen;
(2) an N-protecting group;
(3) alkyl of one to six carbon atoms;
(4) alkenyl of two to six carbon atoms;
(5) alkynyl of two to six carbon atoms;
(6) aryl;
(7) arylalkyl, wherein the alkylene group is of one to six carbon atoms;
(8) cycloalkyl of three to eight carbon atoms and
(9) cycloalkylalkyl, wherein the cycloalkyl group is of three to eight carbon atoms, and the alkylene group is of one to ten carbon atoms; and
wherein, at each occurence, R 2 and R 3 are independently selected from the group consisting of
(1) hydrogen;
(2) alkyl of one to six carbon atoms;
(3) alkenyl of two to six carbon atoms;
(4) alkynyl of two to six carbon atoms;
(5) aryl;
(6) arylalkyl, wherein the alkylene group is of one to six carbon atoms
(7) cycloalkyl of three to eight carbon atoms and
(8) cycloalkylalkyl, wherein the cycloalkyl group is of three to eight carbon atoms, and the alkylene group is of one to ten carbon atoms; and
wherein, at each occurence, X is selected from the group consisting of
(1) O and
(2) S; and
wherein, at each occurence,
m is one to five,
n is zero to four and
t is zero to two; and
wherein, at each occurence, the alkyl, alkenyl, alkynyl, aryl, heterocycle, cycloalkyl, and cycloalkenyl groups are optionally substituted.
2 . A compound according to claim 1 wherein
A and C are hydrogen and
B is —L B R B .
3 . A compound according to claim 2 selected from the group consisting of
7-(2-hydroxyethoxy)-2-naphthalenecarboximidamide mono(trifluoroacetate) salt; methyl 5-[7-[(aminoiminomethyl)-2-naphthalenyl]oxy]pentanoate; mono(trifluoroacetate) salt;
5-[[6-(aminoiminomethyl)-2-naphthalenyl]oxy]pentanoic acid, mono(trifluoroacetate) salt;
methyl 4-[[[7-amino(hydroxyimino)methyl]-2-naphthalenyl] oxy]methyl]benzoate;
methyl 2-[[6-(aminoiminomethyl)-2-naphthalenyl]oxy]acetate, mono(trifluoroacetate) salt;
7-[2-(4-morpholinyl)ethoxy]-2-naphthalenecarboximidamide, bis(trifluoroacetate) salt;
2-[[6-(aminoiminomethyl)-2-naphthalenyl]oxy]acetic acid, mono(trifluoroacetate) salt; and
methyl 4-[6-(aminoiminomethyl)-2-naphthalenyl]oxy]methyl]benzoate, mono(trifluoroacetate) salt.
4 . A compound according to claim 1 wherein
A and B are hydrogen; and
C is —L C R C .
5 . A compound according to claim 4 selected from the group consisting of
8-(carbonylbenzyloxy)amino-2-naphthalenecarboximidamide mono(trifluoroacetate) salt;
N-[7-(aminoiminomethyl)-1-naphthalenyl)acetamide mono(trifluoroacetate) salt;
methyl [7-(aminoiminomethyl)-1-naphthalenyl)carbamate mono(trifluoroacetate) salt;
methyl 3-[[7-(aminoiminomethyl)-1-naphthalenyl]amino]-3-oxopropionate mono(trifluoroacetate) salt;
N-[7-(aminoiminomethyl)-1-naphthalenyl]-2-(phenylmethoxy)acetamide mono(trifluoroacetate) salt;
N-[7-(aminoiminomethyl)-1-naphthalenyl]-1,3-benzodioxole-5-carboxamide mono(trifluoroacetate) salt,
N-[7-(aminoiminomethyl)-1-naphthalenyl]benzenemethanesulfonamide mono(trifluoroacetate) salt,
methyl [7-(aminoiminomethyl)-1-naphthalenyl]methylcarbamate, mono(trifluoroacetate) salt;
propyl [7-(aminoiminomethyl)-1-naphthalenyl]carbamate, mono(trifluoroacetate) salt;
N-[7-(aminoiminomethyl)-1-naphthalenyl]-N′-methylurea, mono(trifluoroacetate) salt;
ethyl [7-(aminoiminomethyl)-1-naphthalenyl)carbamate, mono(trifluoroacetate) salt;
N-[7-(aminoiminomethyl)-1-naphthalenyl)propanamide, mono (trifluoroacetate) salt;
N-[7-(aminoiminomethyl)-1-naphthalenyl)-2-methoxyacetamide, mono(trifluoroacetate) salt;
N-[7-(aminoiminomethyl)-1-naphthalenyl]urea, mono(trifluoroacetate) salt;
N-[7-(aminoiminomethyl)-1-naphthalenyl]-2-hydroxyacetamide, mono(trifluoroacetate) salt;
8-(2-pyrimidinylamino)-2-naphthalenecarboximidamide, bis(trifluoroacetate) salt;
8-amino-2-naphthalenecarboximidamide, bis(trifluoroacetate) salt;
8-(2-pyridinylamino)-2-naphthalenecarboximidamide, bis(trifluoroacetate) salt; and
N-hydroxy-8-(2-pyrimidinylamino)-2-naphthalenecarboximidamide, mono(trifluoroacetate) salt.
6 . A compound according to claim 1 wherein
A is —L A R A ,
B is —L B R B , and
C is hydrogen.
7 . A compound according to claim 6 which is
6, 7-dimethoxy-2-naphthalenecarboximidamide mono(trifluoroacetate) salt.
8 . A compound according to claim 1 wherein
A is —L A R A ;
B is hydrogen; and
C is —L C R C .
9 . A compound according to claim 8 selected from the group consisting of
methyl 6-(aminoiminomethyl)-4-[(methoxycarbonyl)amino]-2-naphthalenecarboxylate mono(trifluoroacetate) salt;
6-methoxy-8-benzyloxy-2-naphthalenecarboximidamide mono(trifluoroacetate) salt;
2-[(7-aminoiminomethyl-3-methoxy-I -naphthalenyl)oxy]acetamide mono(trifluoroacetate) salt;
6-(aminoiminomethyl)-4-(3-furanyl)-N- [4-(trifluoromethyl)phenyl]-2-naphthalenecarboxamide, mono(trifluoroacetate) salt;
6-(aminoiminomethyl)-4-(3-furanyl)-N-(4-pyridinyl)-2-naphthalenecarboxamide, dihydrochloride;
6-(aminoiminomethyl)-4-(3-furanyl)-N-(1H, pyrazol-3-yl)-2-naphthalenecarboxamide, dihydrochloride;
6-(aminoiminomethyl)-4-(3-furanyl)-N-(3-pyridinyl)-2-naphthalenecarboxamide, dihydrochloride;
methyl [7-(aminoiminomethyl)-3-[[[4-(aminomethyl)phenyl]amino]carbonyl]-1-naphathalenyl]carbamate, bis(trifluoroacetate) salt;
6-(aminoiminomethyl)-4-(3-furanyl)-N-(2-pyridinyl)-2-naphthalenecarboxamide, dihydrochloride;
6-(aminoiminomethyl)-4-(3-furanyl)-N-phenyl-2-naphthalenecarboxamide, monohydrochloride;
6-(aminoiminomethyl)-4-[1-(methylsulfonyl)-1H-pyrazol-4-yl]-N-phenyl-2-naphthalenecarboxamide, monohydrochloride;
6-(aminoiminomethyl)-4-[5-(methylthio)-3-furanyl)]-N-phenyl-2-naphthalenecarboxamide, monohydrochloride;
6-(aminoiminomethyl)-N-[4-(aminomethyl)phenyl]-4-(2-pyrimidinylamino)-2-naphthalenecarboxamide, tris(trifluoroacetate) salt;
6-(aminoiminomethyl)-N-phenyl-4-(2-pyrimidinylamino)-2naphthalenecarboxamide, mono(trifluoroacetate) salt;
N-[(4-(aminomethyl)phenyl]-6-[amino(hydroxyimino)methyl]-4-(2-pyrimidinylamino)-2-naphthalenecarboxamide, bis(trifluoroacetate) salt;
6-(aminoiminomethyl)-N-[4-(hydroxymethyl)phenyl]-4-(2-pyrimidinylamino)-2-naphthalenecarboxamide, mono(trifluoroacetate) salt;
methyl [3-[[[4-(aminomethyl)phenyl]amino]carbonyl]-7-[4-amino(hydroxyimino)methyl]-1-naphthalenyl]carbamate, bis(trifluoroacetate) salt;
6-(aminoiminomethyl)-N-phenyl-4-(tetrahydro-3-furanyl)-2-naphthalenecarboxamide,monohydrochloride;
6-[amino(hydroxyimino)methyl]-N-phenyl-4-(2-pyrimidinylamino)-2-naphthalenecarboxamide;
6-(aminoiminomethyl)-4-[5-(ethylthio)-3-furanyl]-N-phenyl-2-naphthalenecarboxamide,monohydrochloride;
6-(aminoiminomethyl)-4-[5-(propylthio)-3-furanyl]-N-phenyl-2-naphthalenecarboxamide,monohydrochloride;
6-(aminoiminomethyl)-N-phenyl-4-(2-pyrrolidinyl)-2-naphthalenecarboxamide, mono(trifluoroacetate) salt;
6-(aminoiminomethyl)-4-[5-(propylsulfonyl)-3-furanyl]-N-phenyl-2-naphthalenecarboxamide, monohydrochloride;
6-(aminoiminomethyl)-4-[5-[methylthio)methyl]-3-furanyl]-N-phenyl-2-naphthalenecarboxamide, monohydrochloride;
6-(aminoiminomethyl)-4-[5-(methoxymethyl)-3-furanyl]-N-phenyl-2-naphthalenecarboxamide, monohydrochloride;
naphthalenecarboxamide, mono(trifluoroacetate) salt; and
6-(aminoiminomethyl)-4-[5-(ethythio)tetrahydro-3-furanyl]-N-phenyl-2-naphthalenecarboxamide, monohydrochloride.
10 . A compound according to claim 1 wherein
A is —L A R A ,
B is —L B R B , and
C is —L C R C .
11 . A compound according to claim 10 which is
6, 7, 8-trimethoxy-2-naphthalenecarboximidamide mono(trifluoroacetate) salt.
12 . A compound according to claim 1 wherein
A is hydrogen;
B is —L B R B ; and
C is L C R C .
13 . A compound according to claim 12 selected from the group consisting of
7, 8-Dimethoxy-2-naphthalenecarboximidamide mono(trifluoroacetate) salt;
2-[(7-aminoiminomethyl)-2-methoxy-1-naphthalenyl)oxy]acetamide mono(trifluoroacetate) salt;
7-benzyloxy-8-iodo-2-naphthalenecarboximidamide mono(trifluoroacetate) salt;
methyl [(7-aminoiminomethyl-2-methoxy-1-naphthalenyl)oxy]acetate mono(trifluoroacetate) salt;
2-[(7-aminoiminomethyl-2-methoxy-1-naphthalenyl)oxy]-yl-acetic acid mono(trifluoroacetate) salt;
1-[(7-aminoiminomethyl-2-methoxy-1-naphthalenyl)oxy]-3-hydroxypropane mono(trifluoroacetate) salt;
1-[(7-aminoiminomethyl-2-methoxy-1-naphthalenyl)oxy]-3-bromopropane mono(hydrochloride) salt;
3-[(7-aminoiminomethyl-2-methoxy-1-naphthalenyl)oxy]propene mono(trifluoroacetate) salt;
1-[(7-aminoiminomethyl-2-methoxy-1-naphthalenyl)oxy]-3-phenylpropane mono(hydrochloride) salt;
1-[(7-aminoiminomethyl-2-methoxy-1-naphthalenyl)oxy]-3-[1-(3,4-dimethoxy)phenyl]propane mono(hydrochloride) salt;
7-methoxy-8-(2-furanyl)-2-naphthalenecarboximidamide mono(trifluoroacetate) salt;
(E)- {7-methoxy-8-[2-(phenyl)ethenyl] } -2-naphthaleneimidamide mono(trifluoroacetate) salt
7-(2 hydroxyethoxy)-8-iodo-2-naphthalenecarboximidamide mono(trifluoroacetate, salt,
7-propoxy-8-iodo-2-naphthalenecarboximidamide mono(trifluoroacetate) salt;
7-methoxy-8-(1H-pyrazol-4-yl)-2-naphthalenecarboximidamide bis(trifluoroacetate) salt;
7-methoxy-8-iodo-2-naphthalenecarboximidamide mono(trifluoroacetate) salt
7-methoxy-8-(3-furanyl)-2-naphthalenecarboximidamide mono(methanesulfonate) salt;
7-methoxy-8-(2-benzofuranyl)naphthalene-2-carboximidamide mono(methanesulfonate) salt;
(E)-8-[2-(1 ,3-benzodioxol-5-yl)ethenyl]-2-naphthalenecarboximidamide mono(methanesulfonate) salt;
(±)-7-methoxy-8-(tetrahydro-3-furanyl)-2-naphthalenecarboximidamide mono(methanesulfonate) salt;
7-methoxy-8-[2-pyrimidinyl(oxy)]-2-naphthalenecarboximidamide mono(trifluoroacetate) salt;
7-methoxy-8-[2-thiazoyl(oxy)]naphthalene-2-carboximidamide mono(trifluoroacetate) salt;
7-methoxy-8-(4-nitrophenoxy)-2-naphthalenecarboximidamide mono(trifluoroacetate) salt;
7-methoxy-8-pentafluorophenoxy-2-naphthalenecarboximidamide mono(trifluoroacetate) salt;
7-methoxy-8-[N-2-pyrimidinyl(amino)]-2-naphthalenecarboximidamide mono(trifluoroacetate) salt;
4-[7-(aminoiminomethyl)-2-methoxy-1-naphthalenyl]dihydro-2(3 H)-fiuranone mono(trifluoroacetate) salt;
7-methoxy-8-(1-acetyl-1H-pyrazolyl)-2-naphthalenecarboximidamide mono(trifluoroacetate) salt;
7-methoxy-8-[1-(methylsulfonyl)-1H-4-pyrazolyl]-2-naphthalenecarboximidamide mono(trifluoroacetate) salt;
6-[2-(4-aminophenyl)ethoxy]-2-naphthalenecarboximidamide mono(trifluoroacetate) salt;
methyl [3-methoxy-6-(aminoiminomethyl)-4-naphthalenyl]carbamate mono(trifluoroacetate) salt;
7-methoxy-8-[2-pyrimidinyl(amino)]-2-naphthalenecarboximidamide bis(trifluoroacetate) salt;
methyl [7-(aminoiminomethyl)-2-methoxy-1-naphthalenyl)carbamate, mono(trifluoroacetate) salt;
7-methoxy-8-(2-pyrimidinylamino)-2-naphthalenecarboximidamide, bis(trifluoroacetate) salt;
7-methoxy-8-[(phenylmethyl)amino]-2-naphthalenecarboximidamide, mono(trifluoroacetate) salt,
7-methoxy-8-(phenylamino)-2-naphthalenecarboximidamide, mono(trifluoroacetate) salt;
7-methoxy-8-[(4-methoxyphenyl)amino]-2-naphthalenecarboximidamide, mono(trifluoroacetate) salt;
(E)-3-[7-(aminoiminomethyl)-2-methoxy-1-naphthalenyl)-2-propenamide, mono(trifluoroacetate) salt;
7-methoxy-8-(3-oxo-1-cyclopenten-1-yl)-2-naphthalenecarboximidamide, mono(trifluoroacetate) salt;
methyl 4-[[[7-(aminoiminomethyl)-1-(2-pyrimidinylamino)-2-naphthalenyl]oxy]methyl]benzoate, mono(trifluoroacetate) salt;
4-[[[7-(aminoiminomethyl)-1-(2-pyrimidinylamino)-2-naphthalenyl]oxy]methyl] benzoic acid, mono(trifluoroacetate) salt;
7-methoxy-8-(pyrazinyloxy)-2-naphthalenecarboximidamide, dimethanesulfonate salt;
7-methoxy-8-(phenylthio)-2-naphthalenecarboximidamide, methanesulfonate; and
7-methoxy-8-(pyrazinylamino)-2-naphthalenecarboximidamide, bis(trifluoroacetate) salt.
14 . A compound selected from the group consisting of
7, 8-dimethoxy-2-naphthalenecarboximidamide mono(trifluoroacetate) salt; 6, 7, 8-trimethoxy-2-naphthalenecarboximidamide mono(trifluoroacetate) salt; 6, 7-dimethoxy-2-naphthalenecarboximidamide mono(trifluoroacetate) salt; 2-[(7-aminoiminomethyl-2-methoxy-1-naphthalenyl)oxy]acetamide mono(trifluoroacetate) salt; 7-benzyloxy-8-iodo-2-naphthalenecarboximidamide mono(trifluoroacetate) salt; methyl [(7-aminoiminomethyl-2-methoxy-1-naphthalenyl)oxy]acetate mono(trifluoroacetate) salt; 2-[(7-aminoiminomethyl-2-methoxy-1-naphthalenyl)oxy]-yl-acetic acid mono(trifluoroacetate) salt; 1-[(7-aminoiminomethyl-2-methoxy-1-naphthalenyl)oxy]-3-hydroxypropane mono(trifluoroacetate) salt; phenylmethyl [7-(aminoiminomethyl)-1-naphthalenyl)carbamate mono(trifluoroacetate) salt; N-[7-(aminoiminomethyl)-1-naphthialenyl)acetamide mono(trifluoroacetate) salt; methyl [7-(aminoiminomethyl)-1-naphthalenlyl)carbamate mono(trifluoroacetate) salt; methyl 3-[[7-(aminoiminomethyl)-1-naphthalenyljamino]-3-oxopropanoate mono(trifluoroacetate) salt; N-[7-(aminoiminomethyl)-1-naphthalenyl1-2-(phenylmethoxy)acetamide mono(trifluoroacetate) salt; N-[7-(aminoiminomethyl)-1-naphthalenyl]-1,3-benzodioxide-3-carboxamide mono(trifluoroacetate) salt; N-[7-(aminoiminomethyl)-1-naphthalenyl]benzenemethanesulfonamide mono(trifluoroacetate) salt; 1-[(7-aminoiminomethyl-2-methoxy-1-naphthalenyl)oxy]-3-bromopropane mono(hydrochloride) salt; 3-[(7-aminoiminomethyl-2-methoxy-1-naphthalenyl)oxy]propene mono(trifluoroacetate) salt; 1-[(7-aminoiminomethyl-2-methoxy-1-naphthalenyl)oxy]-3-phenylpropane mono(hydrochloride) salt; 1-[(7-aminoiminomethyl-2-methoxy-1-naphthalenyl)oxy]-3- [1-(3,4-dimethoxy)phenyl]-propane mono(hydrochloride) salt; 7-methoxy-8-(2-furanyl)-2-naphthalenecarboximidamide mono(trifluoroacetate) salt; methyl 6-(aminoiminomethyl)-4-[(methoxycarbonyl)amino]-2-naphthalenecarboxylate mono(trifluoroacetate) salt; (E)-6-[2-(phenyl)ethenyl]-2-naphthaleneimidamide mono(trifluoroacetate) salt; 7-(2-hydroxyethoxy)-8-iodo-2-naphthalenecarboximidamide mono(trifluoroacetate) salt; 7-(2-hydroxyethoxy)-2-naphthalenecarboximidamide mono(trifluoroacetate) salt; 6-methoxy-8-benzyloxy-2-naphthalenecarboximidamide mono(trifluoroacetate) salt; 2-[(7-aminoiminomethyl-3-methoxy-1-naphthalenyl)oxy]acetamide mono(trifluoroacetate) salt; 7-propoxy-8-iodo-2-naphthalenecarboximidamide mono(trifluoroacetate) salt; 7-methoxy-8-(l H-pyrazol-4-yl)-2-naphthalenecarboximidamide mono(trifluoroacetate) salt; 7-methoxy-8-iodo-2-naphthalenecarboximidamide mono(trifluoroacetate) salt; 7-methoxy-8-(3-furanyl)-2-naphthalenecarboximidamide mono(methanesulfonate) salt; 7-methoxy-8-(2-benzofuranyl)naphthalene-2-carboximidamide mono(methanesulfonate) salt; (E)-8-[2-(1,3-benzodioxol-5-yl)ethenyl]-2-naphthalenecarboximidamide mono(methanesulfonate) salt; (±)-7-methoxy-8-(tetrahydro-3-furanyl)-2-naphthalenecarboximidamide mono(methanesulfonate) salt; 7-methoxy-8-[2-pyrimidinyl(oxy)]-2-naphthalenecarboximidamide mono(trifluoroacetate) salt; 7-methoxy-8-[2-thiazoyl(oxy)]naphthalene-2-carboximidamide mono(trifluoroacetate) salt; 7-methoxy-8-(4-nitrophenoxy)-2-naphthalenecarboximidamide mono(trifluoroacetate) salt; 7-methoxy-8-pentafluorophenoxy-2-naphthalenecarboximidamide mono(trifluoroacetate) salt; 7-methoxy-8-[N-2-pyrimidinyl(amino)]-2-naphthalenecarboximidamide mono(trifluoroacetate) salt; N-(6-aminoiminomethyl-2-naphthalenyl)-N′-benzylurea mono(trifluoroacetate) salt; N-(6-aminoiminomethyl-2-naphthalenyl)-N′-methylurea mono(trifluoroacetate) salt; N-(6-aminoiminomethyl-2-naphthalenyl)-N′-isopropylurea mono(trifluoroacetate) salt; N-(6-aminoiminomethyl-2-naphthalenyl)-N′-phenyl-N′-methylurea mono(trifluoroacetate) salt; 6-aminonaphthalene-2-carboximidamide mono(trifluoroacetate) salt; N-(6-aminoiminomethyl-2-naphthalenyl)-N′-cyclohexylurea mono(trifluoroacetate) salt; N-(6-aminoiminomethyl-2-naphthalenyl)-N′-benzyloxyurea mono(trifluoroacetate) salt; 1, 1-dimethylethyl [4-[[(6-cyano-2-naphthalenyl)amino]carbonyl]phenyl]carbamate mono(trifluoroacetate) salt N-[6-(aminoiminomethyl)-2-naphthalenyl]-4-(aminomethyl)benzamide mono(trifluoroacetate) salt; 4-[7-(aminoiminomethyl)-2-methoxy-1-naphthalenyl]dihydro-2(3H)-furanone mono(trifluoroacetate) salt; 7-methoxy-8-(1-acetyl-1H-pyrazolyl)-2-naphthalenecarboximidamide mono(trifluoroacetate) salt; 7-methoxy-8- [1-(methylsulfonyl)-1H-4-pyrazolyl]-2-naphthalenecarboximidamide mono(trifluoroacetate) salt; methyl [3-methoxy-6-(aminoiminomethyl)-4-naphthalenyl]carbamate mono(trifluoroacetate) salt; 7-methoxy-8-[2-pyrimidinyl(amino)]-2-naphthalenecarboximidamide; and bis(trifluoroacetate) salt.
15 . A method for inhibiting urokinase in a mammal in need of such treatment, comprising adminstering to the mammal a therapeutically effective amount of a compound of claim 1 .
16 . A composition for inhibiting urokinase comprising both a pharmaceutical carrier and a therapeutically effective amount of a compound of claim 1 .Join the waitlist — get patent alerts
Track US2001049374A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.